Mubadala Investment Company in Outset Medical, Inc.
Completed. First disclosed February 11, 2021, in a Schedule 13G (source).
- Investor
- Mubadala Investment Company (United Arab Emirates)
- Target
- Outset Medical, Inc. (EDGAR CIK 1484612)
- Target country
- United States
- Sector
- Health and Life Sciences (SIC 3845)
- First disclosed
- February 11, 2021, Schedule 13G
- Amount
- Not stated
- Stake at first disclosure
- 6.8%
- Latest stated stake
- 3.1% (December 7, 2021)
Source Filings and Releases
| Date | Document | Stated stake | Link |
|---|---|---|---|
| February 11, 2021 | Schedule 13G | 6.8% | View |
| December 7, 2021 | Schedule 13G/A | 3.1% | View |
Cite: Middle East Forum, “Mubadala Investment Company in Outset Medical, Inc.,” Gulf Sovereign Holdings, accessed October 13, 2026, https://statemoney.meforum.org/deal/mubadala-outset-medical-inc-1484612/.
Gulf money also reaches U.S. universities and lobbyists: the Influence Tracker holds Section 117 gift and contract disclosures and FARA registrations, and the Campus Watch Map places that funding on specific campuses.